{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:33:07Z","timestamp":1791232387307,"version":"4.1.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>A 50-year-old man was admitted to our hospital for vomit, nausea, diplopia, and headache resistant to analgesic drugs. Symptoms started the day after his third COVID-19 mRNA vaccine (Moderna) whereas SARS-CoV-2 nasal swab was negative. Pituitary MRI showed recent bleeding in macroadenoma, consistent with pituitary apoplexy. Adverse Drug Reaction was reported to AIFA (Italian Medicines Agency).A stress dexamethasone dose was administered due to the risk of adrenal insufficiency and to reduce oedema. Biochemistry showed secondary hypogonadism; inflammatory markers were elevated as well as white blood cells count, fibrinogen and D-dimer. Pituitary tumour transsphenoidal resection was performed and pathology report was consistent with pituitary adenoma with focal haemorrhage and necrosis; we found immunohistochemical evidence for SARS-CoV-2 proteins next to pituitary capillaries, in the presence of an evident lymphocyte infiltrate.Few cases of pituitary apoplexy after COVID-19 vaccination and infection have been reported. Several hypotheses have been suggested to explain this clinical picture, including cross-reactivity between SARS-CoV-2 and pituitary proteins, COVID-19-associated coagulopathy, infection-driven acutely increased pituitary blood demand, anti-Platelet Factor 4\/heparin antibodies development after vaccine administration. Ours is the first case of SARS-CoV-2 evidence in pituitary tissue, suggesting that endothelial infection of pituitary capillaries could be present before vaccination, possibly due to a previous asymptomatic SARS-CoV-2 infection. Our case underlines that SARS-CoV-2 can associate with apoplexy by penetrating the central nervous system, even in cases of negative nasal swab. Patients with pituitary tumours may develop pituitary apoplexy after exposure to SARS-CoV-2, therefore clinicians should be aware of this risk.<\/jats:p>","DOI":"10.3389\/fendo.2022.1035482","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T04:36:17Z","timestamp":1668659777000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Pituitary apoplexy and COVID-19 vaccination: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Ludovica","family":"Aliberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Bortolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Schiuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Franceschetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gaf\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Borgatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A.","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Zatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01148-1","article-title":"COVID-19 and the pituitary","volume":"24","author":"Frara","year":"2021","journal-title":"Pituitary"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000047","article-title":"Pituitary apoplexy: pathophysiology, diagnosis and management","volume":"59","author":"Glezer","year":"2015","journal-title":"Arch Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2265.2010.03913.x","article-title":"UK Guidelines for the management of pituitary apoplexy","volume":"74","author":"Rajasekaran","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4158\/EP15657.CR","article-title":"A novel association between pituitary tumor apoplexy and influenza a","volume":"2","author":"Yousuf","year":"2016","journal-title":"AACE Clin Case Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/039463201302600201","article-title":"Vaccines and autoimmunity","volume":"26","author":"De Martino","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.25259\/SNI_401_2021","article-title":"Coronavirus disease 2019 infection and pituitary apoplexy: A causal relation or just a coincidence? a case report and review of the literature","volume":"12","author":"Kamel","year":"2021","journal-title":"Surg Neurol Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100821RRR","article-title":"Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage","volume":"35","author":"Bortolotti","year":"2021","journal-title":"FASEB J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2021.09.028","article-title":"Case report: Pituitary apoplexy after COVID-19 vaccination","volume":"158","author":"Pi\u00f1ar-Guti\u00e9rrez","year":"2021","journal-title":"Med Clin (Barc)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.04.716","article-title":"Abstract #1001394: A rare endocrine complication of the COVID-19 vaccine","volume":"27","author":"Jaggi","year":"2021","journal-title":"Endocr Pract"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2022.04.002","article-title":"Pituitary apoplexy following adenoviral vector-based COVID-19 vaccination","author":"Roncati","year":"2022","journal-title":"Brain Hemorrhages"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jecr.2022.100123","article-title":"Pituitary apoplexy after COVID-19 vaccination: A case report","volume":"25","author":"Zainordin","year":"2022","journal-title":"J Clin Transl Endocrinol Case Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01080-w","article-title":"Pituitary apoplexy associated with acute COVID-19 infection and pregnancy","volume":"23","author":"Chan","year":"2020","journal-title":"Pituitary"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211043386","article-title":"A case of hypophysitis following immunization with the mRNA-1273 SARS-CoV-2 vaccine","volume":"9","author":"Murvelashvili","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.02.045","article-title":"Pituitary apoplexy in the setting of COVID-19 infection","volume":"47","author":"LaRoy","year":"2021","journal-title":"Am J Emerg Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1055\/s-0041-1742104","article-title":"Rapidly progressive pituitary apoplexy in a patient with COVID-19 disease treated with endoscopic endonasal surgery","volume":"83","author":"Taneja","year":"2022","journal-title":"J Neurol Surg Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.25259\/SNI_305_2020","article-title":"Pituitary macroadenoma apoplexy in a severe acute respiratory syndrome-coronavirus-2-positive testing: Causal or casual","volume":"11","author":"Solorio-Pineda","year":"2020","journal-title":"Surg Neurol Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa203","article-title":"A rare case of SARS-CoV-2 infection associated with pituitary apoplexy without comorbidities","volume":"5","author":"Ghosh","year":"2021","journal-title":"J Endocr Soc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/13102818.2022.2051738","article-title":"Pituitary apoplexy associated with COVID-19 infection: review and a case report","volume":"36","author":"Popov","year":"2022","journal-title":"Biotechnol Biotechnol Equipment"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-22-0056","article-title":"Pituitary apoplexy in the aftermath of a SARS-CoV-2 infection: a case series from amiens university hospital","volume":"187","author":"Balmain","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01379-2","article-title":"Is there any gender difference in epidemiology, clinical presentation and co-morbidities of non-functioning pituitary adenomas? a prospective survey of a national referral center and review of the literature","volume":"44","author":"Di Somma","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480325","article-title":"Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia","volume":"148","author":"Colao","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00265","article-title":"Autonomic brain centers and pathophysiology of COVID-19","volume":"11","author":"Chigr","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003648","article-title":"Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: possible paths to platelet factor 4 autoimmunity","volume":"18","author":"Goldman","year":"2021","journal-title":"PloS Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI151092","article-title":"Is complement the culprit behind COVID-19 vaccine-related adverse reactions","volume":"131","author":"Mastellos","year":"2021","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2021.1875813","article-title":"Complement activation and coagulopathy - an ominous duo in COVID19","volume":"14","author":"Tomo","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835156","article-title":"Complement activation via the lectin and alternative pathway in patients with severe COVID-19","volume":"13","author":"Niederreiter","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.04.054","article-title":"Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the vaccine adverse event reporting system (VAERS)","volume":"39","author":"Welsh","year":"2021","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/vaccines8030554","article-title":"Inflammasome-mediated immunogenicity of clinical and experimental vaccine adjuvants","volume":"8","author":"Reinke","year":"2020","journal-title":"Vaccines"},{"key":"B31","doi-asserted-by":"publisher","first-page":"103479","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B33","article-title":"COVID-19 treatment guidelines panel","volume-title":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines","year":""}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1035482\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T04:36:20Z","timestamp":1668659780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1035482\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":33,"alternative-id":["10.3389\/fendo.2022.1035482"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1035482","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"article-number":"1035482"}}